ARMP

Conviction 32HealthcareScan · Mon, Aug 10, 2026

ARMP$4.64-1.59%

ResistanceSupportVol 14

Vol MA14 115.22K

May 11May 28Jun 16Jul 6Jul 23Aug 10

Armata Pharmaceuticals, Inc.BIOLOGICAL PRODUCTS, (NO DIAGNOSTIC SUBSTANCES)www.armatapharma.com ↗

Price4.64

Change-1.59%

Gap-1.27%

Rel volume2.52×

Avg volume166.22K

Avg $ vol774.79K

SMA 204.69

SMA 505.90

SMA 2007.59

Price vs 50-21.44%

Price vs 200-38.94%

MA stackbearish

50/200 cross—

Supertrenddown · 5.58

RSI (14)43

MACD hist0.09

MACD cross—

Stoch %K / %D21 / 24

ADX (14)29

+DI / −DI18 / 20

RSI divergence—

MACD divergence—

ATR %+11.29%

ADR %10.67%

52w high14.80

52w low2.36

From 52w high-68.68%

Above 52w low+96.39%

New 52w highNo

SqueezeOff

Bollinger width34.73%

%B0.47

Donchian pos52.14%

Donchian high5.70

Donchian low3.48

AVWAP (52w high)7.77

vs AVWAP high-40.33%

AVWAP (52w low)7.69

vs AVWAP low-39.71%

OBV trendFlat

Chaikin MF (20)0.05

Today vs 20d2.52×

Avg vol (14d)115.22K

Avg vol (20d)166.22K

Avg $ vol (20d)774.79K

Market cap170.15K

RS 3m (vs SPY)-54.22%

RS 6m (vs SPY)-55.82%

RS line new highNo

Trend template3/8

Technical rank20.8

1 week-8.22%

1 month+8.80%

3 months-44.16%

6 months-39.81%

1 year+96.40%

YTD-29.34%

P/E-0.00

P/B-0.00

P/S—

P/FCF-0.01

EPS-4.80

Div yield47.02%

ROE55.78%

ROA-249.00%

Debt/Eq—

Current0.64

EV/EBITDA0.13

Gross margin—

Net margin—

Rev growth—

EPS growth-818.79%

Price target—

Target upside—

Analyst rating—

Institutional—

Ent. value-4.58M

Revenue31K

Net income-115.35M

Gross profit—

Free cash flow-26.3M

IndustryBIOLOGICAL PRODUCTS, (NO DIAGNOSTIC SUBSTANCES)

ExchangeNYSE

Shares out36.71M

Employees61

ListedFri, May 27, 1994

Free float20.26M

Float %55.2%

Short interest704.66K

Days to cover4.5d

Short volume79.1%

Squeeze score65 / 100

Next earnings—

EPS forecast—

Last EPS vs est—

Last surprise—

Setup gradeD

Conviction32 / 100

Pattern quality—

Tech rank20.8 / 100

Group rank86 / 100 · Leading

Status laneNo active setup

Setup direction—

Pattern family

Resistance6.66

Support3.92

Days since event—

Candle confirm—

News sentiment—

Financials as of Tue, Mar 31, 2026 · quarterly.

Congress activity

Disclosed STOCK Act trades in ARMP

All disclosures →

No recent disclosed trades by Congress in ARMP. STOCK Act filings can lag the trade by up to 45 days.

Insider activity

SEC Form 4 transactions in ARMP · 1 buy

Insider	Side	Shares	Value	Traded	Filed
Gilmer Daniel B. Director · Stock Options (Right to Buy) · 2026-04-24	Grant	51.28K	$0	2026-04-24	2026-04-28

SEC filings

EDGAR filings in ARMP · 6 recent

EDGAR →

Get daily signals & real-time alerts.

StockSetups scans ~12,300 US stocks & ETFs after every close and sorts every long setup into four ranked lanes — each with a trade plan — plus an always-on engine firing 35+ real-time intraday alerts. Free for 14 days, cancel in one click.

Start free — 14-day full access →

Educational data, not financial advice. Patterns, levels and the trade plan are algorithmic, not a recommendation to trade.